The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Pulmonary oedema 18
SANDOSTATIN LAR DEPOT Thrombosis 18
SANDOSTATIN Arthralgia 17
SANDOSTATIN Decreased appetite 17
SANDOSTATIN Muscle spasms 17
SANDOSTATIN Neoplasm progression 17
SANDOSTATIN Pneumonia 17
SANDOSTATIN LAR DEPOT 5-hydroxyindolacetic acid in urine increased 17
SANDOSTATIN LAR DEPOT Anal incontinence 17
SANDOSTATIN LAR DEPOT Ascites 17
SANDOSTATIN LAR DEPOT Coma 17
SANDOSTATIN LAR DEPOT Disorientation 17
SANDOSTATIN LAR DEPOT Gastrooesophageal reflux disease 17
SANDOSTATIN LAR DEPOT Injury 17
SANDOSTATIN LAR DEPOT Kidney infection 17
SANDOSTATIN LAR DEPOT Renal pain 17
SANDOSTATIN LAR DEPOT Skin lesion 17
SANDOSTATIN LAR DEPOT Tachycardia 17
SANDOSTATIN LAR DEPOT Varicose vein 17
SANDOSTATIN Dehydration 16

Total Records: 2,045     Number of Pages: 103